Goldman Sachs’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
Other funds holding SBRA
VPM
VCM
N
Goldman Sachs's SBRA Position: Q1 2026 in Review
Goldman Sachs increased its Sabra Healthcare REIT (SBRA) stake by 51% in Q1 2026, buying an estimated $24.7M and bringing the position to 3,733,941 shares worth $71.8M. The position accounts for 0.01% of the portfolio, ranked #1280.
Goldman Sachs first reported a position in SBRA in Q2 2013 and has held it in 52 quarters since. The position peaked at $81.7M in Q1 2022. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- Goldman Sachs held 3,733,941 shares of Sabra Healthcare REIT worth $71.8M as of Q1 2026.
- Goldman Sachs bought 1,253,365 Sabra Healthcare REIT shares in Q1 2026, an estimated $24.7M.
- Sabra Healthcare REIT made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1280 holding.
- Goldman Sachs first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Sabra Healthcare REIT position peaked at $81.7M in Q1 2022.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.